85819-63-2

Upstream product

• 85819-62-1 {3-[2,6-Dibromo-4-(2-{[1-(3-bromo-2,5-dihydroxy-4-methoxy-phenyl)-meth-(E)-ylidene]-amino}-ethyl)-phenoxy]-propyl}-carbamic acid methyl ester 
• 67-56-1 methanol 
• 134755-34-3 3,5-dibromo-4-hydroxy-β-phenethylamine 
• 210546-16-0 [2-(3,5-Dibromo-4-hydroxy-phenyl)-ethyl]-carbamic acid 1-biphenyl-4-yl-1-methyl-ethyl ester 
• 210546-18-2 {2-[4-(3-Amino-propoxy)-3,5-dibromo-phenyl]-ethyl}-carbamic acid 1-biphenyl-4-yl-1-methyl-ethyl ester 
• 210546-19-3 (2-{3,5-Dibromo-4-[3-(cyanocarbonyl-amino)-propoxy]-phenyl}-ethyl)-carbamic acid 1-biphenyl-4-yl-1-methyl-ethyl ester 
• 210546-17-1 (2-{3,5-Dibromo-4-[3-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-propoxy]-phenyl}-ethyl)-carbamic acid 1-biphenyl-4-yl-1-methyl-ethyl ester 

Relevant academic research and scientific papers

Synthesis of ceratinamine and moloka'iamine: Antifouling agents from the marine sponge Pseudoceratina purpurea

Syntheses of the title compounds (4 and 5, respectively) are described together with a biogenetic hypothesis that rationalizes the origin of ceratinamine's unique cyanoformamide functionality.

Two new antibiotics from the Red Sea sponge Psammaplysilla purpurea. Total 13C-NMR line assignment of psammaplysins A and B and aerothionin

Two new tetra bromo metabolites (3 and 4), possessing the hitherto unknown spirocyclohexadienyloxazoline moiety, have been isolated from the sponge Psammaplysilla purpurea. The structure of compounds 3 and 4 have been elucidated by using spectroscopic met